« Back to Record
Juul, N., Szallasi, Z., Eklund, A. C., Li, Q., Burrell, R. A., Gerlinger, M., Valero, V., Andreopoulou, E., Esteva, F. J., Symmans, W. F., Desmedt, C., Haibe-Kains, B., Sotiriou, C., Pusztai, L., & Swanton, C. (2010). Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials. Lancet oncology, 11(4), 358-365. doi:10.1016/S1470-2045(10)70018-8
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/54605



